Race
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
---|---|---|---|---|
Total | - | - | 4,080 | - |
No | - | - | 3,353 | - |
Yes | - | - | 267 | - |
Unknown | - | - | 460 | - |
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender
Visit 2
Male | Female | Total | |
---|---|---|---|
Total | 1,861 | 2,219 | 4,080 |
No | 1,562 | 1,791 | 3,353 |
Yes | 99 | 168 | 267 |
Unknown | 200 | 260 | 460 |
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2)) vs Race
Visit 2
White | Black | Other | Total | |
---|---|---|---|---|
Total | 3,587 | 256 | 237 | 4,080 |
No | 2,927 | 223 | 203 | 3,353 |
Yes | 235 | 19 | 13 | 267 |
Unknown | 425 | 14 | 21 | 460 |